Viewing Study NCT00919061


Ignite Creation Date: 2025-12-24 @ 12:31 PM
Ignite Modification Date: 2026-01-01 @ 5:29 AM
Study NCT ID: NCT00919061
Status: COMPLETED
Last Update Posted: 2016-02-03
First Post: 2009-06-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: